BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30811632)

  • 1. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
    Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
    Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of transferrin receptor 1 and 2 in human hepatocellular carcinoma tissue.
    Sakurai K; Sohda T; Ueda S; Tanaka T; Hirano G; Yokoyama K; Morihara D; Aanan A; Takeyama Y; Irie M; Iwata K; Syakado S; Noritomiz T; Yamashita Y; Sakisaka S
    Hepatogastroenterology; 2014; 61(130):426-30. PubMed ID: 24901155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma.
    Babu KR; Muckenthaler MU
    Sci Rep; 2019 Feb; 9(1):1518. PubMed ID: 30728365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
    Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
    BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 9. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.
    Kindrat I; Tryndyak V; de Conti A; Shpyleva S; Mudalige TK; Kobets T; Erstenyuk AM; Beland FA; Pogribny IP
    Oncotarget; 2016 Jan; 7(2):1276-87. PubMed ID: 26657500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
    Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
    J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.
    Herbison CE; Thorstensen K; Chua AC; Graham RM; Leedman P; Olynyk JK; Trinder D
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1567-75. PubMed ID: 19828835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
    Gao J; Jia WD
    Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma.
    Kijima H; Sawada T; Tomosugi N; Kubota K
    BMC Cancer; 2008 Jun; 8():167. PubMed ID: 18541040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
    Hu X; He B; Zhou L; Xie H; Zheng S
    Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.